1. 133 Development of novel cellular therapeutics for metastatic and primary CNS malignancies. (9th November 2020) Authors: Rennert, Paul; Birt, Alyssa; Su, Lihe; Wu, Lan; Dufort, Fay; Lobb, Roy; Ambrose, Christine; Rennert, Paul Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 133 Development of novel cellular therapeutics for metastatic and primary CNS malignancies. (9th November 2020) Authors: Rennert, Paul; Birt, Alyssa; Su, Lihe; Wu, Lan; Dufort, Fay; Lobb, Roy; Ambrose, Christine; Rennert, Paul Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Gene expression profiling of rubella virus infected primary endothelial cells of fetal and adult origin. Issue 1 (December 2016) Authors: Geyer, Henriette; Bauer, Michael; Neumann, Jennifer; Lüdde, Amy; Rennert, Paul; Friedrich, Nicole; Claus, Claudia; Perelygina, Ludmilla; Mankertz, Annette Journal: Virology journal Issue: Volume 13:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Glyco-engineered HEK 293-F cell lines for the production of therapeutic glycoproteins with human N-glycosylation and improved pharmacokinetics. (5th January 2021) Authors: Uhler, Rico; Popa-Wagner, Ruth; Kröning, Mario; Brehm, Anja; Rennert, Paul; Seifried, Annegrit; Peschke, Madeleine; Krieger, Markus; Kohla, Guido; Kannicht, Christoph; Wiedemann, Philipp; Hafner, Mathias; Rosenlöcher, Julia Journal: Glycobiology Issue: Volume 31:Number 7(2021) Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗